查找临床试验
已按「胶质母细胞瘤」检索，对应国际通用词 glioblastoma
共找到 47 项正在招募的试验（在中国／港澳台设有中心）
数据更新于 00:19，每 5 分钟自动同步正在招募早期 I 期中国有中心NCT07538128
Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma
China
年龄 18 Years – 不限
Huashan Hospital
正在招募不适用中国有中心NCT07552233
NK Cell Therapy for Malignant Solid Brain Tumors
China
年龄 18 Years – 70 Years
Peking University Third Hospital
正在招募早期 I 期中国有中心NCT07067905
Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
China
年龄 18 Years – 不限
Chinese PLA General Hospital
正在招募II 期中国有中心NCT04115761
Evaluate the Efficacy and Safety of ADCV01 as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients
Taiwan
年龄 20 Years – 75 Years
Ever Supreme Bio Technology Co., Ltd.
正在招募III 期中国有中心NCT06496971
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
Taiwan
年龄 18 Years – 80 Years
NaviFUS Corporation
正在招募早期 I 期中国有中心NCT07655869
[177Lu]Lu-DOTA-EB-RGD2 Therapy in Patients With Recurrent High-grade Glioma
China
年龄 18 Years – 不限
Beijing Tiantan Hospital
正在招募II 期中国有中心NCT07670026
Intensified Adjuvant Therapy for High-Risk Newly Diagnosed Glioblastoma With Subtotal Resection or Short-Term Progression
China
年龄 18 Years – 不限
Second Affiliated Hospital, Zhejiang University, School of Medicine
正在招募I 期 / II 期中国有中心NCT07318818
A Clinical Trial of P134 Cells in Recurrent Glioblastoma
China
年龄 18 Years – 70 Years
Tasly Pharmaceutical Group Co., Ltd
正在招募I 期 / II 期中国有中心NCT07410676
EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors
China
年龄 不限 – 不限
Essen Biotech
正在招募不适用中国有中心NCT05990244
Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion
China
年龄 18 Years – 80 Years
Shengjing Hospital
正在招募I 期 / II 期中国有中心NCT06914128
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
United States、Australia、Belgium、China、Czechia 等 12 国
年龄 18 Years – 不限
Bayer
正在招募III 期中国有中心NCT05303519
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
United States、Australia、China
年龄 18 Years – 不限
Nuvation Bio Inc.